Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Cancer drug resistance induced by EMT: novel therapeutic strategies
Javier De Las Rivas, Anamaria Brozović, Sivan Izraely, et al.
Archives of Toxicology (2021) Vol. 95, Iss. 7, pp. 2279-2297
Open Access | Times Cited: 142

Showing 1-25 of 142 citing articles:

The molecular mechanisms and therapeutic strategies of EMT in tumor progression and metastasis
Yuhe Huang, Weiqi Hong, Xiawei Wei
Journal of Hematology & Oncology (2022) Vol. 15, Iss. 1
Open Access | Times Cited: 441
Rational combinations of targeted cancer therapies: background, advances and challenges
Haojie Jin, Liqin Wang, René Bernards
Nature Reviews Drug Discovery (2022) Vol. 22, Iss. 3, pp. 213-234
Closed Access | Times Cited: 223
Battling Chemoresistance in Cancer: Root Causes and Strategies to Uproot Them
Alisha Ramos, Samira Sadeghi, Hossein Tabatabaeian
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 17, pp. 9451-9451
Open Access | Times Cited: 162
Targeting epigenetic regulators to overcome drug resistance in cancers
Nan Wang, Ting Ma, Bin Yu
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 141
Triple-negative breast cancer metastasis involves complex epithelial-mesenchymal transition dynamics and requires vimentin
Eloïse M. Grasset, Matthew Dunworth, Gaurav Sharma, et al.
Science Translational Medicine (2022) Vol. 14, Iss. 656
Open Access | Times Cited: 101
Loss of cancer-associated fibroblast-derived exosomal DACT3-AS1 promotes malignant transformation and ferroptosis-mediated oxaliplatin resistance in gastric cancer
Xianlin Qu, Bing Liu, Longgang Wang, et al.
Drug Resistance Updates (2023) Vol. 68, pp. 100936-100936
Closed Access | Times Cited: 78
Heterogeneity and plasticity of epithelial–mesenchymal transition (EMT) in cancer metastasis: Focusing on partial EMT and regulatory mechanisms
Dandan Li, Lingyun Xia, Pan Huang, et al.
Cell Proliferation (2023) Vol. 56, Iss. 6
Open Access | Times Cited: 73
Utilizing non-coding RNA-mediated regulation of ATP binding cassette (ABC) transporters to overcome multidrug resistance to cancer chemotherapy
Kenneth K.W. To, Zoufang Huang, Hang Zhang, et al.
Drug Resistance Updates (2024) Vol. 73, pp. 101058-101058
Closed Access | Times Cited: 17
Hallmarks of cancer resistance
Muhammad Tufail, Jia-Ju Hu, Jie Liang, et al.
iScience (2024) Vol. 27, Iss. 6, pp. 109979-109979
Open Access | Times Cited: 14
Triple-Negative Breast Cancer Progression and Drug Resistance in the Context of Epithelial–Mesenchymal Transition
Ewa Błaszczak, Paulina Miziak, Adrian Odrzywolski, et al.
Cancers (2025) Vol. 17, Iss. 2, pp. 228-228
Open Access | Times Cited: 1
Targeting mitochondria as a potential therapeutic strategy against chemoresistance in cancer
Soumi Mukherjee, Gurjit Kaur Bhatti, Ravindresh Chhabra, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 160, pp. 114398-114398
Open Access | Times Cited: 36
Promising applications of nanotechnology in inhibiting chemo-resistance in solid tumors by targeting epithelial-mesenchymal transition (EMT)
Mona Tangsiri, Ali Hheidari, Mahsa Liaghat, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 170, pp. 115973-115973
Open Access | Times Cited: 26
Contribution of Autophagy to Epithelial Mesenchymal Transition Induction during Cancer Progression
Raffaele Strippoli, Reyhaneh Niayesh‐Mehr, Maryam Adelipour, et al.
Cancers (2024) Vol. 16, Iss. 4, pp. 807-807
Open Access | Times Cited: 12
Clinical impact of epithelial–mesenchymal transition for cancer therapy
Nobendu Mukerjee, Sagnik Nag, Bikramjit Bhattacharya, et al.
Clinical and Translational Discovery (2024) Vol. 4, Iss. 1
Open Access | Times Cited: 8
Writers, readers, and erasers RNA modifications and drug resistance in cancer
Di Chen, Xinyu Gu, Yeltai Nurzat, et al.
Molecular Cancer (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 8
Epithelial–Mesenchymal Transition Signaling and Prostate Cancer Stem Cells: Emerging Biomarkers and Opportunities for Precision Therapeutics
Luiz Paulo Chaves, Camila Morais Melo, Fabiano Pinto Saggioro, et al.
Genes (2021) Vol. 12, Iss. 12, pp. 1900-1900
Open Access | Times Cited: 48
SOX2 function in cancers: Association with growth, invasion, stemness and therapy response
Sepideh Mirzaei, Mahshid Deldar Abad Paskeh, Maliheh Entezari, et al.
Biomedicine & Pharmacotherapy (2022) Vol. 156, pp. 113860-113860
Closed Access | Times Cited: 36
Cancer-educated mammary adipose tissue-derived stromal/stem cells in obesity and breast cancer: spatial regulation and function
Andreas Ritter, Nina‐Naomi Kreis, Susanne Roth, et al.
Journal of Experimental & Clinical Cancer Research (2023) Vol. 42, Iss. 1
Open Access | Times Cited: 19
Snail transcription factors as key regulators of chemoresistance, stemness and metastasis of ovarian cancer cells
Michał Kiełbik, Patrycja Przygodzka, Izabela Szulc-Kiełbik, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2023) Vol. 1878, Iss. 6, pp. 189003-189003
Open Access | Times Cited: 19
Targeting Glucose Metabolism in Cancer Cells as an Approach to Overcoming Drug Resistance
Andrea Cunha, Patrícia Silva, Bruno Sarmento, et al.
Pharmaceutics (2023) Vol. 15, Iss. 11, pp. 2610-2610
Open Access | Times Cited: 19
The potential of using circulating tumour cells and their gene expression to predict docetaxel response in metastatic prostate cancer
Caitlin R. Davies, Tianyu Guo, Edwina Burke, et al.
Frontiers in Oncology (2023) Vol. 12
Open Access | Times Cited: 15
Deciphering the complexities of cancer cell immune evasion: Mechanisms and therapeutic implications
Ishita Gupta, Ola Hussein, Konduru S. Sastry, et al.
Advances in Cancer Biology - Metastasis (2023) Vol. 8, pp. 100107-100107
Open Access | Times Cited: 15
AM-DMF-SCP: Integrated Single-Cell Proteomics Analysis on an Active Matrix Digital Microfluidic Chip
Zhicheng Yang, Kai Jin, Yi‐Min Chen, et al.
JACS Au (2024) Vol. 4, Iss. 5, pp. 1811-1823
Open Access | Times Cited: 6
lncRNAs: New players of cancer drug resistance via targeting ABC transporters
Mohammad Ebrahimnezhad, Sanaz Hassanzadeh Asl, Maede Rezaie, et al.
IUBMB Life (2024) Vol. 76, Iss. 11, pp. 883-921
Closed Access | Times Cited: 6
Mesenchymal–epithelial transition and AXL inhibitor TP-0903 sensitise triple-negative breast cancer cells to the antimalarial compound, artesunate
Mirko Terragno, Anastassiya Vetrova, Oleg Semenov, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 5
Page 1 - Next Page

Scroll to top